Salveo Capital
Overview
Private investment fund focused on the legalized cannabis industry. Salveo Capital is committed to shaping this young industry by providing funding and development to companies with the will and vision to be the future faces of legal marijuana. As legalization spreads, completely fresh territories open up for those nimble enough to act quickly and decisively.
Investment Focus
- Accredited investors
- Qualified purchasers
Portfolio Companies
Reach Salveo Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Salveo Capital
What sectors does Salveo Capital invest in?
Salveo Capital invests in Financial Services, Software, Business Services, Cannabis, Ag-tech and Bio-Pharma, and is based in Chicago, Illinois, United States. Salveo Capital is listed as a vc in the ConnectSafely investor database.
What stage does Salveo Capital invest at?
Salveo Capital backs companies at Seed, Early Stage, Series A, Series B and Growth, writing cheques of 15M - 25M.
Which regions does Salveo Capital invest in?
Salveo Capital invests across United States.
Who are the partners at Salveo Capital?
Team members listed for Salveo Capital include Michael Gruber (Managing Partner) and Alex Thiersch (Partner).
What companies has Salveo Capital invested in?
Salveo Capital's portfolio includes Headset, Front Range Biosciences, PathogenDx, Flow Kana, KelSie Biotech, Wurk and Harborside.
How do I contact Salveo Capital?
Salveo Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
